Limba
Romanian
Romanian
English|
Bemarituzumab (Anti-FGFR2 / CD332), 1mg*25
15.481,90 RON
SKU
SKM_A2497_1mg*25
Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD.
| Price | 13.010,00 RON (preturile sunt fara TVA) |
|---|---|
| Description |
Bemarituzumab (Anti-FGFR2 / CD332) is a first-in-class, humanized IgG1 monoclonal antibody against FGFR2b (a FGF receptor). Bemarituzumab blocks fibroblast growth factors from binding and activating FGFR2b. Bemarituzumab has the potential for cancer research. MW: 145.24 KD. |
